I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
II. A EUROPEAN MARKET REPORT
1.INDUSTRY OVERVIEW
A Prelude
Market Opportunity
Breast Cancer: A Common Malignancy Among Females in the Western World
Increased Instances of Breast Cancer in Younger Women!
European Biopsy Devices Market
Widespread Adoption of Advanced Diagnostic Systems Will Increase Demand for Breast Biopsy Devices
Key Statistics:
Table 1: Worldwide Breast Cancer Incidence Rates & Mortality Rate (Per 100,000 persons) for the year 2007 (includes corresponding Graph/Chart)
Table 2: Percentage of Five-Year Survival Rate For Breast Cancer by Cancer Stage (includes corresponding Graph/Chart)
Competitive Scenario:
Current Market Conditions
Impact of Recession
Key Market Trends & Issues: A Review
Continuous Fight Against Cancer: A Key Propeller for Growth
Population Aging Makes Rise Of Cancer Diagnostics Inevitable
Table 3: Probability of Developing Breast Cancer by Age Group
Table 4: Probability of Surviving Breast Cancer by Age Group (includes corresponding Graph/Chart)
Table 5: Population Over 65 Years and Above in North America, Western Europe and Eastern Europe for the year 2007 (In Millions) (includes corresponding Graph/Chart)
Promising Developments in Breast Cancer Diagnosis Underway
Needle Biopsy Score Over Open Biopsy
Widespread Awareness Among Patients & Practitioners: The Need of the Hour
Rise in Use of Breast Markers
Rise in Use of MRI Guided Breast Biopsy
Government Breast Cancer Screening Programs Drive Biopsy Devices Market
Rise in Use of Single Insertion Breast Biopsy Needle
Roll Out of Integrated Breast Centers
Vacuum-Assisted Biopsy Gain Physician Preference
Table 6: Reimbursement Benefits for Vacuum-Assisted Over Core Needle Biopsy in Office Based Setting in the US Market for the year 2007
Reimbursement & Price Sensitivity: Key Challenges for Breast Biopsy Market
Susceptibility to Radiation Exposure May Hinder Growth
Competing Solutions May Limit Need of Breast Biopsy Procedures
High Costs of Biopsy Markers May Constrain Growth
Pricing Factors
Technology Innovations in Breast Care Management:
Breast Thermography - An Alternative to Mammography
Advanced MRI Technique May Limit Breast Biopsies in Women
Identification of New Genes May Improve Breast Cancer Diagnosis
Innovative MRI Technique Identifies Cancerous Breast Tumors
2.REGIONAL PERSPECTIVE
Europe
Market Overview
Changing Physician Preferences Shape Breast Biopsy Market
Market Restraints
Key Statistics:
Table 7: Top Three Cancers Among Europeans for the year 2006 (includes corresponding Graph/Chart)
Table 8: European Age-Standardised Rate (ASR) for Breast Cancer Incidence per 100, 000 Individuals, By Country, for the year 2006 (includes corresponding Graph/Chart)
Table 9: European Age-Standardised Rate (ASR) for Breast Cancer Mortality per 100, 000 Individuals, By Country, for the year 2006 (includes corresponding Graph/Chart)
Germany
Italy
Table 10: Female Breast Cancer Cases in Italy (2005): Breakdown of Mortality, Incidence and Prevalence by Number of Cases for Key Italian Regions (includes corresponding Graph/Chart)
United Kingdom
Role of Government
Key Statistics:
Table 11: Percentage Share Breakdown of Common Causes of Female Cancer Deaths in the UK for the year 2007 (includes corresponding Graph/Chart)
Table 12: Breakdown of New Breast Cancer Cases Diagnosed in the UK by Gender for the year 2006 (includes corresponding Graph/Chart)
Table 13: Breakdown of Breast Cancer Mortality in the UK by Gender for the year 2007 (includes corresponding Graph/Chart)
Other Western Nations: Facts & Figures
United States
Key Statistics:
Table 14: Breast Cancer in the United States: Breakdown of Incidence Rate By Ethnic Group for the year 2007
Table 15: Breast Cancer in the United States: Breakdown of Mortality Rate By Ethnic Group for the year 2007
Table 16: Breakdown of Number of Breast Biopsy Procedures in the United States for the Years 2008 & 2013 (Number of Procedures in 000s) (includes corresponding Graph/Chart)
Table 17: US Breast Biopsy Devices Market (2008): Percentage Share Breakdown of Revenues by Key Players (includes corresponding Graph/Chart)
Table 18: US Vaccuum-Assisted Breast Biopsy Disposables Market (2007): Percentage Share Breakdown of Revenues by Key Players (includes corresponding Graph/Chart)
Table 19: US Vaccuum-Assisted Biopsy Procedures (2007): Percentage Share Breakdown by Procedures Type (includes corresponding Graph/Chart)
Table 20: US Biopsy Products Market (2008): Percentage Share Breakdown of Revenues by Product Segment (includes corresponding Graph/Chart)
Canada
Table 21: New Breast Cancer-Related Diagnosis in Canada (2007): Percentage Share Breakdown of Female Breast Cancer Incidence by Age Group (includes corresponding Graph/Chart)
Table 22: Breast Cancer-Related Deaths in Canada (2007): Percentage Share Breakdown of Female Breast Cancer Related Death by Age Group (includes corresponding Graph/Chart)
3.PRODUCT OVERVIEW
Breast Cancer
Risk Factors
Breast Cancer Screening
Breast Cancer Diagnosis
Breast Biopsy
Breast Biopsy Procedures
Surgical Biopsy
Needle Biopsy
Fine Needle Aspiration
Core Needle Biopsy
Vacuum-Assisted Biopsy
Commonly Used Breast Biopsy Devices
Spring Loaded Biopsy Needle
Vacuum-Assisted Core Biopsy Device
Minimally Invasive Breast Biopsy (MIBB) Device
Advanced Breast Biopsy Instrumentation (ABBI) Device
Mammotome
Advances in Breast Imaging Techniques
Ultrasound Image Guidance
Stereotactic Image Guidance
Magnetic Resonance Imaging
Mammotome® Breast Biopsy System
Digital Spot-View Mammography Enhances Breast Biopsy
Biopsy Tissue Markers
4.PRODUCT INNOVATIONS/INTRODUCTIONS
Senorx Unveils New Model of Senosonix System
SenoRx to Release StarchMark™
SenoRx Unveils EnCor®
Siemens Healthcare Launches New Biopsy Device
5.RECENT INDUSTRY ACTIVITY
Terason Enters into Agreement with SenoRx
SenoRx Receives CE Mark Rights for Contura™ MLB
RevMed Inks a Global License with SPD
Sanarus Technologies Acquires Sanarus Medical
Hologic Obtains CE Mark Approval for Celero®
Echoserve, SenoRx Enter Into Co-Promotion Deal
Naviscan Receives FDA’s Approval for Stereo Navigator™
Volcano Acquires Novelis
SenoRx Receives CE Mark Approval for SenoSonix
Hologic Completes Merger with Cytyc Corporation
6.FOCUS ON SELECT PLAYERS
C. R. Bard Inc. (USA)
Bard Biopsy Systems (USA)
Cardinal Health, Inc. (USA)
Ethicon Endo-Surgery, Inc (USA)
GE Healthcare (UK)
Hologic, Inc. (USA)
iCAD, Inc. (USA)
Intact Medical Corporation (USA)
Koninklijke Philips Electronics N.V. (The Netherlands)
Rubicor Medical, Inc., (USA)
Sanarus Technologies, LLC (USA)
SenoRx, Inc (USA)
Siemens AG (Germany)
7.GLOBAL MARKET PERSPECTIVE
Table 23: European Recent Past, Current & Future Analysis for Breast Biopsy Devices with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 24: European Historic Review for Breast Biopsy Devices with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
III. COMPETITIVE LANDSCAPE
Total Companies Profiled: 25 (including Divisions/Subsidiaries - 31)
Region/CountryPlayers
The United States
Japan
Europe
Germany
The United Kingdom
Italy
Rest of Europe
Middle-East